Rahul Sharma is an Endocrinology/Metabolic physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3 Riverside Cir
Roanoke, VA 240164955
Telephone
540-224-5170Provider last certified this registry record 15 Dec 2023.
Clinical trials
- ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
Sponsor: Edwards Lifesciences
- Radial Versus Femoral Secondary Access During TAVI
Sponsor: Carilion Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sekisui Diagnostics LLCProgram year20251 payment
- Sekisui Diagnostics, LLCProgram year20241 payment
- Insulet CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
79.8%GLP-1 receptor agonist25.3%Ozempic48%Trulicity30%Mounjaro22%Part D≥54 patientsInsulin Analog24.2%Lantus Solostar23%Novolog Flexpen16%Insulin Lispro Kwikpen U-10013%Tresiba Flextouch U-2009%Humalog Kwikpen U-1008%Levemir Flexpen7%Basaglar Kwikpen U-1006%Toujeo Solostar5%Toujeo Max Solostar5%Humalog4%Tresiba Flextouch U-1004%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
14%l-Thyroxine8.5%Levothyroxine Sodium100%Part D≥51 patientsThyroid Hormone Synthesis Inhibitor3%Methimazole100%Part D≥18 patients+ 2 more classes in this area
Sensory organs
2.5%Corticosteroid2.5%Dexamethasone53%Hydrocortisone47%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2016–2025 per NIH RePORTER. The latest:
- The University of Virginia Kidney Technology Development Research Education Program (VA K-TUTOR)
University of Virginia
FY2024$139,326R25DK124918
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”